IS5792A - Aðferð til þess að vinna efnasambönd úr lyfjablómum af varablómaætt sem hafa neikvæða virkni á veirur - Google Patents

Aðferð til þess að vinna efnasambönd úr lyfjablómum af varablómaætt sem hafa neikvæða virkni á veirur

Info

Publication number
IS5792A
IS5792A IS5792A IS5792A IS5792A IS 5792 A IS5792 A IS 5792A IS 5792 A IS5792 A IS 5792A IS 5792 A IS5792 A IS 5792A IS 5792 A IS5792 A IS 5792A
Authority
IS
Iceland
Prior art keywords
flowered
viruses
alternate
compounds
preparation
Prior art date
Application number
IS5792A
Other languages
English (en)
Inventor
K Han Myun
Lee Paul
Original Assignee
Georgetown University (Us/Us)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georgetown University (Us/Us) filed Critical Georgetown University (Us/Us)
Publication of IS5792A publication Critical patent/IS5792A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F246/00Copolymers in which the nature of only the monomers in minority is defined
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
IS5792A 1998-06-25 2000-12-22 Aðferð til þess að vinna efnasambönd úr lyfjablómum af varablómaætt sem hafa neikvæða virkni á veirur IS5792A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/104,363 US6037369A (en) 1998-06-25 1998-06-25 Compounds obtained from salvia species having antiviral Activity
PCT/US1999/014297 WO1999066942A1 (en) 1998-06-25 1999-06-25 Compounds obtained from salvia species having antiviral activity

Publications (1)

Publication Number Publication Date
IS5792A true IS5792A (is) 2000-12-22

Family

ID=22300096

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5792A IS5792A (is) 1998-06-25 2000-12-22 Aðferð til þess að vinna efnasambönd úr lyfjablómum af varablómaætt sem hafa neikvæða virkni á veirur

Country Status (18)

Country Link
US (1) US6037369A (is)
EP (1) EP1089747A1 (is)
JP (1) JP2002518455A (is)
KR (1) KR20010071580A (is)
CN (1) CN1312722A (is)
AU (1) AU740698B2 (is)
BR (1) BR9912218A (is)
CA (1) CA2335956A1 (is)
CZ (1) CZ20004858A3 (is)
HU (1) HUP0103398A2 (is)
ID (1) ID28792A (is)
IL (1) IL140483A0 (is)
IS (1) IS5792A (is)
MX (1) MXPA01000195A (is)
NO (1) NO20006631L (is)
PL (1) PL345086A1 (is)
TR (1) TR200100450T2 (is)
WO (1) WO1999066942A1 (is)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001505583A (ja) * 1996-12-05 2001-04-24 ジョージタウン ユニヴァーシティー 抗ウイルス活性を有するサルビア種の抽出物
US6043276A (en) * 1998-06-25 2000-03-28 Georgetown University School Of Medicine Compounds obtained from salvia species having antiviral activity
WO2001085189A1 (de) * 2000-05-05 2001-11-15 Parsenn-Produkte Ag Zubereitung zur topischen behandlung von durch virusinfektionen verursachten manifestationen
SG98409A1 (en) * 2000-06-21 2003-09-19 Chi Chiang Yang Pharmaceutical compositions and combinations for the treatment or prophylaxis of disorders related to hiv and retrovirus
JP2002020283A (ja) * 2000-06-22 2002-01-23 Yang Chi-Chiang Hivおよびレトロウイルスに関連する障害の処置または予防のための薬学的組成物および組み合わせ
KR20020005222A (ko) * 2000-06-28 2002-01-17 치-치앙 양 Hiv 또는 레트로바이러스에 관련된 질환의 치료 또는예방용 약학적 조성물 및 조합물
US7071227B2 (en) * 2000-09-26 2006-07-04 The Johns Hopkins University Antiviral compositions and methods of use
US20070027209A1 (en) * 2005-08-01 2007-02-01 Lee Hyun C Prevention and treatment of atherosclerosis with lithospermate B
US20100174097A1 (en) * 2007-03-28 2010-07-08 Man Kil Jung Method for isolation of high concentration of magnesium lithospermate b from salviae miltiorrhizae
JP5755633B2 (ja) * 2009-03-30 2015-07-29 タスリー・ファーマシューティカル・グループ・カンパニー・リミテッドTasly Pharmaceutical Group Co., Ltd. 新規サルビアノール酸化合物l、その調製方法及び使用
CN101919836A (zh) * 2009-06-17 2010-12-22 山东绿叶天然药物研究开发有限公司 迷迭香酸的新用途
CN103054976B (zh) * 2011-10-21 2014-09-24 上海中医药大学 一种治疗血小板减少症的中药组合物及其制备方法和应用
CN103845403B (zh) * 2014-02-27 2016-10-05 河南大学 丹参配方颗粒在制备预防和治疗艾滋病脑病药物方面的应用
CN104974119B (zh) * 2014-04-01 2018-10-19 中国科学院上海药物研究所 一种高纯度丹酚酸b镁及其制备方法
CN108042524A (zh) * 2017-12-21 2018-05-18 南方医科大学 丹酚酸b及其结构类似物在制备抗hpv病毒感染药物中的应用
CN109771410B (zh) * 2019-03-06 2020-11-24 湖北大学 紫草酸在制备抗乙肝病毒药物中的用途
CN109771407B (zh) * 2019-03-29 2021-11-26 成都医学院 迷迭香酸在制备抑制水痘-带状疱疹病毒的药物中的用途
CN110922286B (zh) * 2019-11-23 2022-08-16 上海化工研究院有限公司 一种非对称芳基取代富烯化合物及其制备方法与应用
US20230210848A1 (en) * 2020-04-30 2023-07-06 Fujifilm Toyama Chemical Co., Ltd. Coronavirus infection therapeutic agent formed through combination of pyrazine derivative and another coronavirus infection therapeutic drug
CN114712342B (zh) * 2022-05-10 2023-04-21 湖北大学 紫草酸在制备抗流感病毒药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178865A (en) * 1990-06-19 1993-01-12 Cedars-Sinai Medical Center Chinese herbal extracts in the treatment of hiv related disease in vitro
US5346695A (en) * 1991-03-27 1994-09-13 Tampa Bay Research Institute Methods of inhibiting HIV replication in vitro using polymers of p-hydroxylated cinnamic acids
JP2001505583A (ja) * 1996-12-05 2001-04-24 ジョージタウン ユニヴァーシティー 抗ウイルス活性を有するサルビア種の抽出物

Also Published As

Publication number Publication date
JP2002518455A (ja) 2002-06-25
PL345086A1 (en) 2001-12-03
WO1999066942A9 (en) 2000-06-22
CN1312722A (zh) 2001-09-12
IL140483A0 (en) 2002-02-10
BR9912218A (pt) 2002-07-23
US6037369A (en) 2000-03-14
EP1089747A1 (en) 2001-04-11
HUP0103398A2 (hu) 2002-01-28
CA2335956A1 (en) 1999-12-29
CZ20004858A3 (cs) 2001-09-12
NO20006631D0 (no) 2000-12-22
AU740698B2 (en) 2001-11-15
AU4714999A (en) 2000-01-10
WO1999066942A1 (en) 1999-12-29
NO20006631L (no) 2001-02-26
MXPA01000195A (es) 2002-04-24
ID28792A (id) 2001-07-05
KR20010071580A (ko) 2001-07-28
TR200100450T2 (tr) 2001-07-23

Similar Documents

Publication Publication Date Title
IS5792A (is) Aðferð til þess að vinna efnasambönd úr lyfjablómum af varablómaætt sem hafa neikvæða virkni á veirur
DK1123284T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1173431T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1296656T3 (da) Fremgangsmåde til fremstilling af et præparat
DK1159274T3 (da) Fremgangsmåde til fremstilling af citalopram
DK0916675T3 (da) Fremgangsmåde til fremstilling af sildenafil
DK1232152T3 (da) Forbedret fremgangsmåde til fremstilling af nitrogensubstituerede aminotetraliner
DK1008577T4 (da) Fremgangsmåde til fremstilling af methanol
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
FI20011622A (fi) Menetelmä sitalopraamin valmistamiseksi
DK1349580T3 (da) Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning
DK1206436T3 (da) Retinoider til behandling af emfysem
DK1199927T3 (da) Fremgangsmåde til fremstilling af ammoniumglyphosatpulver
DK1958938T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid
DK1114664T3 (da) Fremgangsmåde til separation af bestanddelene i en dispersion
DK1446107T3 (da) Fremgangsmåde til fremstilling af tabletter omfattende s-adenosylmethionin
DK1296970T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1092243T3 (da) Fremgangsmåde til fremstilling af en mikroporøs film
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
NO20000933D0 (no) Fremgangsmåte for fremstilling av polymer
DK1228056T3 (da) Fremgangsmåde til fremstilling af citalopram
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0971931T3 (da) Fremgangsmåde itl debenzylering af dibenzylbiotin